Full-Time

Full Stack Software Engineer 3

Post Billing Processing System

Posted on 1/11/2025

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Compensation Overview

$99.3k - $124.1k/yr

Mid, Senior

Company Historically Provides H1B Sponsorship

Austin, TX, USA

Category
Full-Stack Engineering
Software Engineering
Required Skills
Kubernetes
Agile
Python
JavaScript
React.js
MySQL
Git
Node.js
Postgres
Docker
AWS
Vue.js
MongoDB
REST APIs
Flask
AngularJS
HTML/CSS
Django
Requirements
  • Strong proficiency in programming languages such as Python and/or Node.js.
  • Experience with front-end technologies (e.g., React, Angular, Vue.js, HTML, CSS, JavaScript).
  • Experience with back-end frameworks (e.g., Express, Django, Flask).
  • Experience with relational databases (e.g., PostgreSQL, MySQL) and/or NoSQL databases (e.g., MongoDB, DynamoDB).
  • Experience designing and consuming RESTful APIs.
  • Experience with cloud platforms (AWS preferred) and core services (e.g., EC2, S3, RDS, Lambda).
  • Experience with containerization technologies (Docker, Kubernetes).
  • Experience with version control systems (Git).
  • Understanding of software development lifecycle (SDLC) and agile methodologies.
  • Strong analytical and problem-solving skills.
  • Excellent communication and collaboration skills.
  • Ability to work effectively in a team environment.
  • Strong organizational and time management abilities.
  • Attention to detail and commitment to delivering high-quality, reliable software.
  • Ability to work in a fast-paced, dynamic environment.
Responsibilities
  • Design, develop, test, deploy, and maintain the full stack of the Post Billing Processing system, including front-end interfaces, back-end services, databases, and infrastructure components (e.g., Denial Code Manager, Workflow Orchestrator, Template Generation Engine, Outbound Package Preparation, Automated Outbound Communication).
  • Collaborate with business stakeholders, product managers, and other engineers to understand requirements and translate them into technical specifications and robust, scalable software solutions.
  • Develop and manage APIs for internal and external system integrations.
  • Implement and manage database schemas and optimize queries for performance.
  • Work with cloud services (AWS) for deployment, monitoring, and scaling.
  • Contribute to the implementation and optimization of automated workflows (e.g., using AWS Step Functions).
  • Participate in code reviews, testing (unit, integration, end-to-end), and optimization efforts.
  • Create and maintain comprehensive documentation for system architecture, components, APIs, and processes.
  • Ensure system security, data privacy, and compliance with healthcare regulations (e.g., HIPAA).
  • Provide ongoing support and maintenance, troubleshooting and resolving issues promptly.
  • Stay updated with the latest advancements in full-stack development technologies and best practices.
Desired Qualifications
  • Hands-on experience with LLMs (e.g., OpenAI APIs, Llama2, Mistral) and integrating them into applications.
  • Familiarity with AI/ML frameworks like LangChain, LangGraph, or Haystack.
  • Experience building RAG (Retrieval-Augmented Generation) solutions.
  • Knowledge of Vector Databases (e.g., Pinecone, Milvus) or Graph Databases (e.g., Neo4j).
  • Understanding of prompt engineering techniques.
  • Experience with advanced RAG techniques (e.g., HyDE, LLM reranking).
  • Experience creating embeddings (e.g., using Ada models).

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology, cell-free DNA (cfDNA) testing, analyzes DNA fragments in the blood to detect minimal traces of cancer and monitor transplanted organ health. Natera differentiates itself by offering personalized tests like the Signatera ctDNA test and the Panorama NIPT for prenatal screening, along with remote genetic counseling services. The company's goal is to enhance patient care through specialized testing that informs treatment decisions and supports family planning.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for personalized medicine supports Natera's genetic testing services.
  • The global NIPT market is expected to reach $7.3 billion by 2025.
  • Increased adoption of liquid biopsy tests aligns with Natera's cfDNA focus.

What critics are saying

  • Expansion into new Austin space could strain financial resources.
  • Increased competition from companies like Lantheus Holdings threatens market share.
  • HEROES trial for breast cancer may face regulatory hurdles or delays.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical applications.
  • Their Signatera test offers personalized ctDNA analysis for cancer patients.
  • Natera's Panorama NIPT has conducted over 2 million non-invasive prenatal tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↓ -1%

2 year growth

↑ 5%
PRWeb
May 30th, 2025
The Melanoma Research Foundation To Host The Denver Miles For Melanoma 5K

The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT. We are excited to share that Kyle Speller, PA Announcer for the Denver Nuggets, will be returning as our emcee on event day! We're also excited to welcome back local sponsor, Cara Mia Dermatology, who will be providing free on-site skin screenings—helping our community stay sun-safe while supporting a great cause.DENVER, May 29, 2025 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT

Intelligence360
May 15th, 2025
Natera To Spend $9.9 Million To Occupy 30,000 Square Feet Of Space In Austin Texas.

Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas. Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas.Austin, Texas — According to state and local development sources, Natera plans to invest $9,900,000.00 to build out 30,000 square feet of new space in Austin. The company plans to occupy the new space at 13011A McCallen Pass in Austin, on or about January 1, 2026. According to the company website Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, womens health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment

TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

INACTIVE